“To decrease CHG utilization, this study assessed selective daily administration of CHG bathing to intensive care unit patients who had an MRSA-positive result or a central venous catheter.” Armellino et al (2014).
Armellino, D., Woltmann, J., Parmentier, D., Musa, N., Eichorn, A., Silverman, R., Hirschwerk, D. and Farber, B. (2014) Modifying the risk: Once-a-day bathing “at risk” patients in the intensive care unit with chlorhexidine gluconate. AJIC: American Journal of Infection Control. 42(5), p.571-573.
Chlorhexidine gluconate (CHG) decreases hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) that can cause colonization and infection. A standard approach is the bathing of all patients with CHG to prevent MRSA transmission. To decrease CHG utilization, this study assessed selective daily administration of CHG bathing to intensive care unit patients who had an MRSA-positive result or a central venous catheter. This risk-based approach was associated with a 72% decrease in hospital-acquired MRSA transmission rate.
Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).
- Guide for intravenous chemotherapy and associated vascular access devices from Macmillan.
- CancerUK IV chemotherapy information.